209k views
0 votes
Moderna Vaccine Phase 3 Clinical Trials

a. What distinguishes Phase 3 Clinical Trials from earlier phases in vaccine development?
b. How is the efficacy of the Moderna Vaccine measured in Phase 3?
c. What is the significance of large-scale testing in Phase 3 trials?
d. When is a vaccine considered ready for regulatory approval after Phase 3?

User Wendel
by
8.3k points

1 Answer

7 votes

Final answer:

Phase 3 clinical trials for the Moderna vaccine assess its efficacy on a large scale to ensure safety and effectiveness before seeking regulatory approval.

Step-by-step explanation:

Phase 3 clinical trials are distinguished from earlier phases by their large-scale testing, involving up to several thousands of patients. This is crucial to establish the efficacy and safety profile of a compound like the Moderna vaccine. The efficacy is measured by looking at how well the vaccine prevents the disease compared to a placebo and is determined by the number of symptomatic, laboratory-confirmed COVID-19 cases in the vaccinated group versus the control group. Large-scale testing in these trials is significant because it provides a comprehensive database that reflects a diverse population and how the vaccine performs across varied demographics and health conditions. A vaccine like Moderna's is considered ready for regulatory approval after Phase 3 if it demonstrates clear benefits that outweigh any risks and can be considered effective and safe for public use.

User Trzy Gracje
by
8.3k points
Welcome to QAmmunity.org, where you can ask questions and receive answers from other members of our community.